secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-06-11T23:59:59+00:00
Accession:  0001213900-25-053292
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo Therapeutics announces 1-for-20 reverse stock split effective June 13, 2025
--------------------------------------------------------------------------------

- Outstanding shares reduced from ~10,321,839 to ~516,092; par value $0.0001 unchanged.
- Split-adjusted trading begins June 13 under symbol CERO; new CUSIP 71902K402.
- No fractional shares; fractional holders receive rounding up to next whole share.
- Proportional adjustments made to outstanding options, warrants, and preferred stock.
- Stockholders approved a 1-for-2 to 1-for-25 range at May 29, 2025 annual meeting; board set 1-for-20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/0001213900-25-053292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025053292/ea0245328-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-053292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer